doxorubicin
Heart failure frequently develops in patients treated with       doxorubicin (Adriamycin), when they receive a cumulative dose greater than 500       mg/m2.
 @OBJECT$  frequently develops in patients  @PREDICAT$  with        @SUBJECT$  (Adriamycin), when they receive a cumulative dose greater than 500       mg/m2.